Postoperative Drainage in Total Knee Arthroplasty in the Presence of Tranexamic Acid
1 other identifier
interventional
42
1 country
1
Brief Summary
The investigator's aim with this study is to address, with the new paradigm of tranexamic acid, the role of wound drainage following total knee arthroplasty in blood loss, blood transfusion requirements and functional recovery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2019
CompletedFirst Posted
Study publicly available on registry
April 16, 2019
CompletedStudy Start
First participant enrolled
August 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedFebruary 15, 2021
February 1, 2021
2.7 years
April 12, 2019
February 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Total RBC loss
Total red blood cells loss after surgery
96 hours
Total RBC loss
Total red blood cells loss after surgery
24 hours
Total RBC loss
Total red blood cells loss after surgery
1 hour
Blood transfusion requirements
Blood transfusions requirements
96 hours
Knee Society Score score
Knee Society Score measuring function of Knee (0-100 total score, higher values, better outcome)
14 days
Secondary Outcomes (22)
Haematocrit level
1 hour
Haematocrit level
24 hours
Haematocrit level
96 hours
Haemoglobin level
1 hour
Haemoglobin level
24 hours
- +17 more secondary outcomes
Study Arms (2)
With drain
EXPERIMENTALParticipants who received a drain during surgery
Without drain
NO INTERVENTIONParticipants who did not receive a drain during surgery
Interventions
Eligibility Criteria
You may qualify if:
- Consecutive patients admitted to perform a primary unilateral total knee arthroplasty
You may not qualify if:
- Contraindication to take tranexamic acid
- hematologic disease with a higher risk of bleeding
- abnormal coagulation tests
- refusal of blood transfusions
- inadequate preoperatory optimization
- deformity \>15⁰ of varus or valgus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Beatriz Angelo
Loures, 2674-514, Portugal
Related Publications (11)
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014 Jul;73(7):1323-30. doi: 10.1136/annrheumdis-2013-204763. Epub 2014 Feb 19.
PMID: 24553908BACKGROUNDNIH Consensus Panel. NIH Consensus Statement on total knee replacement December 8-10, 2003. J Bone Joint Surg Am. 2004 Jun;86(6):1328-35. doi: 10.2106/00004623-200406000-00031. No abstract available.
PMID: 15173310BACKGROUNDBanerjee S, Kapadia BH, Issa K, McElroy MJ, Khanuja HS, Harwin SF, Mont MA. Postoperative blood loss prevention in total knee arthroplasty. J Knee Surg. 2013 Dec;26(6):395-400. doi: 10.1055/s-0033-1357491. Epub 2013 Oct 11.
PMID: 24122437BACKGROUNDHuang GP, Jia XF, Xiang Z, Ji Y, Wu GY, Tang Y, Li J, Zhang J. Tranexamic Acid Reduces Hidden Blood Loss in Patients Undergoing Total Knee Arthroplasty: A Comparative Study and Meta-Analysis. Med Sci Monit. 2016 Mar 10;22:797-802. doi: 10.12659/msm.895571.
PMID: 26961597BACKGROUNDWang H, Shen B, Zeng Y. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee. 2014 Dec;21(6):987-93. doi: 10.1016/j.knee.2014.09.010. Epub 2014 Oct 23.
PMID: 25450009BACKGROUNDZhang Y, Zhang JW, Wang BH. Efficacy of tranexamic acid plus drain-clamping to reduce blood loss in total knee arthroplasty: A meta-analysis. Medicine (Baltimore). 2017 Jun;96(26):e7363. doi: 10.1097/MD.0000000000007363.
PMID: 28658157BACKGROUNDLiao L, Chen Y, Tang Q, Chen YY, Wang WC. Tranexamic acid plus drain-clamping can reduce blood loss in total knee arthroplasty: A systematic review and meta-analysis. Int J Surg. 2018 Apr;52:334-341. doi: 10.1016/j.ijsu.2018.01.040. Epub 2018 Feb 3.
PMID: 29408472BACKGROUNDCraik JD, Ei Shafie SA, Kidd AG, Twyman RS. Can local administration of tranexamic acid during total knee arthroplasty reduce blood loss and transfusion requirements in the absence of surgical drains? Eur J Orthop Surg Traumatol. 2014 Apr;24(3):379-84. doi: 10.1007/s00590-013-1206-1. Epub 2013 Mar 14.
PMID: 23494778BACKGROUNDYang Y, Lv YM, Ding PJ, Li J, Ying-Ze Z. The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial. Eur J Orthop Surg Traumatol. 2015 Jan;25(1):135-9. doi: 10.1007/s00590-014-1461-9. Epub 2014 May 10.
PMID: 24816760BACKGROUNDGao FQ, Li ZJ, Zhang K, Sun W, Zhang H. Four Methods for Calculating Blood-loss after Total Knee Arthroplasty. Chin Med J (Engl). 2015 Nov 5;128(21):2856-60. doi: 10.4103/0366-6999.168041.
PMID: 26521781BACKGROUNDNadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962 Feb;51(2):224-32. No abstract available.
PMID: 21936146BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Afonso Cardoso
Hospital Beatriz Angelo
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 12, 2019
First Posted
April 16, 2019
Study Start
August 22, 2019
Primary Completion
May 1, 2022
Study Completion
July 1, 2022
Last Updated
February 15, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share